Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process.
Market Analysis and Insights: Global Drug Developing Platforms by Artificial Intelligence (AI) Market
The global Drug Developing Platforms by Artificial Intelligence (AI) market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drug Developing Platforms by Artificial Intelligence (AI) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Drug Developing Platforms by Artificial Intelligence (AI) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Drug Developing Platforms by Artificial Intelligence (AI) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Drug Developing Platforms by Artificial Intelligence (AI) include Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM and Microsoft, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Drug Developing Platforms by Artificial Intelligence (AI) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Drug Developing Platforms by Artificial Intelligence (AI), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Developing Platforms by Artificial Intelligence (AI), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Developing Platforms by Artificial Intelligence (AI) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Drug Developing Platforms by Artificial Intelligence (AI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Drug Developing Platforms by Artificial Intelligence (AI) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM and Microsoft, etc.
By Company
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
Google
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
厂肠丑谤枚诲颈苍驳别
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica
Segment by Type
Software
System
Service
Product
Others
Segment by Application
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Developing Platforms by Artificial Intelligence (AI) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Developing Platforms by Artificial Intelligence (AI) companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Developing Platforms by Artificial Intelligence (AI) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Software
1.2.3 System
1.2.4 Service
1.2.5 Product
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Generate Data and Models
1.3.3 Repurpose Existing Drugs
1.3.4 Generate Novel Drug Candidates
1.3.5 Validate and Optimize Drug Candidates
1.3.6 Design Drugs
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Perspective (2018-2029)
2.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Growth Trends by Region
2.2.1 Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Region (2018-2023)
2.2.3 Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Region (2024-2029)
2.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Dynamics
2.3.1 Drug Developing Platforms by Artificial Intelligence (AI) Industry Trends
2.3.2 Drug Developing Platforms by Artificial Intelligence (AI) Market Drivers
2.3.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Challenges
2.3.4 Drug Developing Platforms by Artificial Intelligence (AI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug Developing Platforms by Artificial Intelligence (AI) by Players
3.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue by Players (2018-2023)
3.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Players (2018-2023)
3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio
3.4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Developing Platforms by Artificial Intelligence (AI) Revenue in 2022
3.5 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI) Head office and Area Served
3.6 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
3.7 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Developing Platforms by Artificial Intelligence (AI) Breakdown Data by Type
4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Type (2018-2023)
4.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Type (2024-2029)
5 Drug Developing Platforms by Artificial Intelligence (AI) Breakdown Data by Application
5.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Application (2018-2023)
5.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
6.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
6.2.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
6.2.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
6.2.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
6.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
6.3.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
6.3.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
6.3.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
6.4 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
6.4.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
6.4.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
7.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
7.2.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
7.2.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
7.2.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
7.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
7.3.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
7.3.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
7.3.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
7.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
7.4.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
7.4.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
8.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
8.2.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
8.2.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
8.2.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
8.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
8.3.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
8.3.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
8.3.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
9.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
9.2.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
9.2.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
9.2.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
9.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
9.3.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
9.3.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
9.3.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
9.4 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region
9.4.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023)
9.4.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Antidote
11.1.1 Antidote Company Details
11.1.2 Antidote Business Overview
11.1.3 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.1.4 Antidote Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.1.5 Antidote Recent Developments
11.2 Atomwise
11.2.1 Atomwise Company Details
11.2.2 Atomwise Business Overview
11.2.3 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.2.4 Atomwise Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.2.5 Atomwise Recent Developments
11.3 Turbine
11.3.1 Turbine Company Details
11.3.2 Turbine Business Overview
11.3.3 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.3.4 Turbine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.3.5 Turbine Recent Developments
11.4 Cambridge Cancer Genomics
11.4.1 Cambridge Cancer Genomics Company Details
11.4.2 Cambridge Cancer Genomics Business Overview
11.4.3 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.4.4 Cambridge Cancer Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.4.5 Cambridge Cancer Genomics Recent Developments
11.5 Row Analytics
11.5.1 Row Analytics Company Details
11.5.2 Row Analytics Business Overview
11.5.3 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.5.4 Row Analytics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.5.5 Row Analytics Recent Developments
11.6 Deep Genomics
11.6.1 Deep Genomics Company Details
11.6.2 Deep Genomics Business Overview
11.6.3 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.6.4 Deep Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.6.5 Deep Genomics Recent Developments
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Details
11.7.2 Insilico Medicine Business Overview
11.7.3 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.7.4 Insilico Medicine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.7.5 Insilico Medicine Recent Developments
11.8 IBM
11.8.1 IBM Company Details
11.8.2 IBM Business Overview
11.8.3 IBM Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.8.4 IBM Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.8.5 IBM Recent Developments
11.9 Microsoft
11.9.1 Microsoft Company Details
11.9.2 Microsoft Business Overview
11.9.3 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.9.4 Microsoft Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.9.5 Microsoft Recent Developments
11.10 Google
11.10.1 Google Company Details
11.10.2 Google Business Overview
11.10.3 Google Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.10.4 Google Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.10.5 Google Recent Developments
11.11 AiCure
11.11.1 AiCure Company Details
11.11.2 AiCure Business Overview
11.11.3 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.11.4 AiCure Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.11.5 AiCure Recent Developments
11.12 Calico
11.12.1 Calico Company Details
11.12.2 Calico Business Overview
11.12.3 Calico Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.12.4 Calico Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.12.5 Calico Recent Developments
11.13 Iktos
11.13.1 Iktos Company Details
11.13.2 Iktos Business Overview
11.13.3 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.13.4 Iktos Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.13.5 Iktos Recent Developments
11.14 GNS Healthcare
11.14.1 GNS Healthcare Company Details
11.14.2 GNS Healthcare Business Overview
11.14.3 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.14.4 GNS Healthcare Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.14.5 GNS Healthcare Recent Developments
11.15 Genpact
11.15.1 Genpact Company Details
11.15.2 Genpact Business Overview
11.15.3 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.15.4 Genpact Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.15.5 Genpact Recent Developments
11.16 Biovista
11.16.1 Biovista Company Details
11.16.2 Biovista Business Overview
11.16.3 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.16.4 Biovista Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.16.5 Biovista Recent Developments
11.17 NuMedii
11.17.1 NuMedii Company Details
11.17.2 NuMedii Business Overview
11.17.3 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.17.4 NuMedii Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.17.5 NuMedii Recent Developments
11.18 BenevolentAI
11.18.1 BenevolentAI Company Details
11.18.2 BenevolentAI Business Overview
11.18.3 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.18.4 BenevolentAI Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.18.5 BenevolentAI Recent Developments
11.19 BERG
11.19.1 BERG Company Details
11.19.2 BERG Business Overview
11.19.3 BERG Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.19.4 BERG Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.19.5 BERG Recent Developments
11.20 厂肠丑谤枚诲颈苍驳别
11.20.1 厂肠丑谤枚诲颈苍驳别 Company Details
11.20.2 厂肠丑谤枚诲颈苍驳别 Business Overview
11.20.3 厂肠丑谤枚诲颈苍驳别 Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.20.4 厂肠丑谤枚诲颈苍驳别 Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.20.5 厂肠丑谤枚诲颈苍驳别 Recent Developments
11.21 Nuritas
11.21.1 Nuritas Company Details
11.21.2 Nuritas Business Overview
11.21.3 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.21.4 Nuritas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.21.5 Nuritas Recent Developments
11.22 Exscientia
11.22.1 Exscientia Company Details
11.22.2 Exscientia Business Overview
11.22.3 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.22.4 Exscientia Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.22.5 Exscientia Recent Developments
11.23 Kairntech
11.23.1 Kairntech Company Details
11.23.2 Kairntech Business Overview
11.23.3 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.23.4 Kairntech Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.23.5 Kairntech Recent Developments
11.24 Concerto HealthAI (SymphonyAI)
11.24.1 Concerto HealthAI (SymphonyAI) Company Details
11.24.2 Concerto HealthAI (SymphonyAI) Business Overview
11.24.3 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.24.4 Concerto HealthAI (SymphonyAI) Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.24.5 Concerto HealthAI (SymphonyAI) Recent Developments
11.25 NVIDIA Corporation
11.25.1 NVIDIA Corporation Company Details
11.25.2 NVIDIA Corporation Business Overview
11.25.3 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.25.4 NVIDIA Corporation Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.25.5 NVIDIA Corporation Recent Developments
11.26 Sirenas
11.26.1 Sirenas Company Details
11.26.2 Sirenas Business Overview
11.26.3 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.26.4 Sirenas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.26.5 Sirenas Recent Developments
11.27 Standigm
11.27.1 Standigm Company Details
11.27.2 Standigm Business Overview
11.27.3 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.27.4 Standigm Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.27.5 Standigm Recent Developments
11.28 Transcriptic
11.28.1 Transcriptic Company Details
11.28.2 Transcriptic Business Overview
11.28.3 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.28.4 Transcriptic Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.28.5 Transcriptic Recent Developments
11.29 Cloud Pharmaceuticals
11.29.1 Cloud Pharmaceuticals Company Details
11.29.2 Cloud Pharmaceuticals Business Overview
11.29.3 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.29.4 Cloud Pharmaceuticals Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.29.5 Cloud Pharmaceuticals Recent Developments
11.30 Cyclica
11.30.1 Cyclica Company Details
11.30.2 Cyclica Business Overview
11.30.3 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.30.4 Cyclica Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.30.5 Cyclica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
Google
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
厂肠丑谤枚诲颈苍驳别
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica
听
听
*If Applicable.
